Downstream processing means the purification and recovery of biosynthetic products, especially pharmaceuticals, from sources that are natural such as tissues of animals or plants or fermentation broth. Downstream processing also includes the recycling of components that can be salvaged and proper treatment and disposal of waste.
Downstream processing is used to manufacture antibiotics, antibodies, hormones such as insulin, vaccines and in the production of industrial enzymes. The increasing incidences of the spread of infectious diseases like hepatitis, dengue, swine flu etc. is boosting the propagation of downstream processing market as there is a great demand for effective vaccines for such fatal diseases.
Another important factor leading to the progress of the global downstream processing market is the phenomenal growth of the biopharmaceuticals industry that is leading to an ever growing demand for biopharmaceutical products.
According to the assessment of Future Market Insights, the global downstream processing market is forecasted to reach a figure of about US$ 25,800 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.
North America Market Set to Dominate the Global Downstream Processing Market in Terms of Revenue
The market in North America is set to dominate the global downstream processing market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America downstream processing market is the most attractive market, growing at a robust CAGR over the forecast period.
Chromatography Columns and Resins Segment Slated to Touch a Value of Nearly US$ 10,400 Mn in 2022
According to the projections of Future Market Insights, the chromatography columns and resins segment is expected to reach a value of about US$ 10,400 Mn in the year 2022. This signifies a robust CAGR during the forecast period of 2017-2022. The chromatography columns and resins segment is estimated to account for more than one-third of the revenue share of the product type segment by the end of the year 2017 and is expected to gain in market share by 2022 over 2017.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Biopharmaceutical Manufacturers Segment to Exhibit a CAGR of Nearly 14.0% During the Assessment Period
According to the assessment of Future Market Insights, the biopharmaceutical manufacturers segment is poised to touch a figure of about US$ 15,700 Mn in the year 2022. This signifies a CAGR of nearly 14.0% during the assessment period from 2017 till the year 2022. The biopharmaceutical manufacturers segment is estimated to account for nearly two-thirds of the revenue share of the end users segment by the end of the year 2017 and is projected to gain market share by 2022 over 2017.
The report also profiles companies that are expected to remain active in the expansion of global downstream processing market through 2022, which include Thermo Fisher Scientific, Inc., General Electric Company, Merck & Co Inc., Danaher Corporation, 3M Company, Eppendorf AG, Sartorius Aktiengesellschaft, Repligen Corporation, Lonza Group Ltd. and Corning Incorporated.
- Chromatography Columns and Resins
- Membrane Adsorbers
- Single-use Products
- Consumables and Accessories
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Monoclonal Antibody Production
- Vaccine Production
- Insulin Production
- Immunoglobulin Production
- Erythropoietin Production
- Other Application
- Gel Chromatography
- Ion Exchange Chromatography
- Affinity Chromatography
- Hydrophobic Interaction Chromatography
- Tangential Flow Filtration
- North America
- Latin America
- Asia Pacific excluding Japan
- Middle East and Africa